Trials
Search / Trial NCT06419426

Prospective Study on Febrile Batteries in Pediatric Oncohaematological Patients (SuBiTo)

Launched by ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA · May 16, 2024

Trial Information

Current as of February 19, 2025

Active, not recruiting

Keywords

ClinConnect Summary

Bacterial infections are the most frequent cause of infectious morbidity and mortality in the patient undergoing chemotherapy or hemopoietic stem cell transplantation (TCSE). The main predisposing factor is the impairment of innate immunity as a result of the alteration of mucous barriers (mucositis/enteritis from chemotherapy or radiotherapy), skin (CVC) and neutropenia (non-specific haematological toxicity due to chemotherapy or radiotherapy on bones with hemopoietic marrow). The most frequent form of infection is represented by fever whose cause remains indeterminate in 60-80% of cases. ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • written informed consent,- onset of fever after chemotherapy or after hemopoietic stem cell transplantation (TCSE),
  • endovenous antibiotic therapy for at least 72 hours for the treatment of the febrile episode.
  • ordinary hospitalization scheme
  • age \< 18

About Associazione Italiana Ematologia Oncologia Pediatrica

The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP) is a leading Italian organization dedicated to advancing research and treatment in pediatric hematology and oncology. Comprising a network of specialized centers and healthcare professionals, AIEOP focuses on improving the diagnosis, management, and outcomes of childhood blood disorders and cancers. Through collaborative clinical trials and innovative research initiatives, AIEOP aims to enhance therapeutic strategies, promote evidence-based practices, and ultimately ensure better health prospects for children affected by these critical conditions. The organization is committed to fostering interdisciplinary partnerships and advancing scientific knowledge in the field to improve the quality of care for young patients.

Locations

Bolzano, , Italy

Milano, , Italy

Parma, , Italy

Pavia, , Italy

Catania, , Italy

Verona, Italia, Italy

Ancona, , Italy

Bari, , Italy

Bologna, , Italy

Brescia, , Italy

Cagliari, , Italy

Ferrara, , Italy

Firenze, , Italy

Genova, , Italy

Modena, , Italy

Monza, , Italy

Napoli, , Italy

Padova, , Italy

Palermo, , Italy

Perugia, , Italy

Pescara, , Italy

Roma, , Italy

San Giovanni Rotondo, , Italy

Torino, , Italy

Trieste, , Italy

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0